{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:00:50Z","timestamp":1780700450104,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.7759\/cureus.110317","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:10:57Z","timestamp":1780697457000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-cell Lymphoma Associated With Exposure to Agent Orange"],"prefix":"10.7759","author":[{"given":"Christopher","family":"Tom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Klickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70358-4","article-title":"A review of human carcinogens-part F: chemical agents and related occupations","volume":"10","author":"Baan R\ufeff","year":"2009","unstructured":"Baan R\ufeff, Grosse Y\ufeff, Straif K\ufeff, et al.. A review of human carcinogens-part F: chemical agents and related occupations. Lancet Oncol. 2009, 10:1143-4. 10.1016\/s1470-2045(09)70358-4","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104483","article-title":"Increased risk of head and neck cancer in Agent Orange exposed Vietnam Era veterans","volume":"100","author":"Mowery A","year":"2020","unstructured":"Mowery A, Conlin M, Clayburgh D. Increased risk of head and neck cancer in Agent Orange exposed Vietnam Era veterans. Oral Oncol. 2020, 100:104483. 10.1016\/j.oraloncology.2019.104483","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-362830","article-title":"Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies","volume":"119","author":"Castillo JJ","year":"2012","unstructured":"Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012, 119:4845-50. 10.1182\/blood-2011-06-362830","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.5011","article-title":"Agent Orange exposure and dementia diagnosis in US veterans of the Vietnam era","volume":"78","author":"Martinez S","year":"2021","unstructured":"Martinez S, Yaffe K, Li Y, Byers AL, Peltz CB, Barnes DE. Agent Orange exposure and dementia diagnosis in US veterans of the Vietnam era. JAMA Neurol. 2021, 78:473-7. 10.1001\/jamaneurol.2020.5011","journal-title":"JAMA Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000503095","article-title":"Performance Status Assessment by using ECOG (Eastern Cooperative Oncology Group) Score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam F","year":"2019","unstructured":"Azam F, Latif MF, Farooq A, Tirmazy SH, AlShahrani S, Bashir S, Bukhari N. Performance Status Assessment by using ECOG (Eastern Cooperative Oncology Group) Score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2019, 12:728-36. 10.1159\/000503095","journal-title":"Case Rep Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt E","year":"2024","unstructured":"Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024, 403:1791-807. 10.1016\/S0140-6736(23)02705-8","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.26787","article-title":"Polygenic risk, Agent Orange exposure, and lymphoid neoplasms in the Veterans Affairs Million Veteran Program","volume":"8","author":"Teng X","year":"2025","unstructured":"Teng X, Wan JY, Gupta P, Li W, Cozen W, Ma H. Polygenic risk, Agent Orange exposure, and lymphoid neoplasms in the Veterans Affairs Million Veteran Program. JAMA Netw Open. 2025, 8:e2526787. 10.1001\/jamanetworkopen.2025.26787","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070406","article-title":"Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression","volume":"171","author":"Vogel CF","year":"2007","unstructured":"Vogel CF, Li W, Sciullo E, et al.. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol. 2007, 171:1538-48. 10.2353\/ajpath.2007.070406","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099586","article-title":"TCDD promotes lung tumors via attenuation of apoptosis through activation of the Akt and ERK1\/2 signaling pathways","volume":"9","author":"Chen RJ","year":"2014","unstructured":"Chen RJ, Siao SH, Hsu CH, et al.. TCDD promotes lung tumors via attenuation of apoptosis through activation of the Akt and ERK1\/2 signaling pathways. PLoS One. 2014, 9:e99586. 10.1371\/journal.pone.0099586","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2938","article-title":"Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand Veteran Cohort Study","volume":"1","author":"Landgren O","year":"2015","unstructured":"Landgren O, Shim YK, Michalek J, et al.. Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand Veteran Cohort Study. JAMA Oncol. 2015, 1:1061-8. 10.1001\/jamaoncol.2015.2938","journal-title":"JAMA Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15132","article-title":"Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma","volume":"49","author":"Su TH","year":"2019","unstructured":"Su TH, Liu CJ, Tseng TC, et al.. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Aliment Pharmacol Ther. 2019, 49:589-98. 10.1111\/apt.15132","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05412-1","article-title":"High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy","volume":"102","author":"Visentini M","year":"2023","unstructured":"Visentini M, Pica A, D'Ippolito G, et al.. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy. Ann Hematol. 2023, 102:3457-63. 10.1007\/s00277-023-05412-1","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1324113","article-title":"Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP","volume":"15","author":"Zhan Z","year":"2024","unstructured":"Zhan Z, Guo W, Wan X, et al.. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP. Front Immunol. 2024, 15:1324113. 10.3389\/fimmu.2024.1324113","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0756","article-title":"Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era","volume":"25","author":"Cheng CL","year":"2020","unstructured":"Cheng CL, Huang SC, Chen JH, et al.. Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era. Oncologist. 2020, 25:793-802. 10.1634\/theoncologist.2019-0756","journal-title":"Oncologist"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17142","article-title":"Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study","volume":"192","author":"Huang HH","year":"2021","unstructured":"Huang HH, Hsiao FY, Chen HM, Wang CY, Ko BS. Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study. Br J Haematol. 2021, 192:110-8. 10.1111\/bjh.17142","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO Provisional Clinical Opinion update","volume":"38","author":"Hwang JP","year":"2020","unstructured":"Hwang JP, Feld JJ, Hammond SP, et al.. Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO Provisional Clinical Opinion update. J Clin Oncol. 2020, 38:3698-715. 10.1200\/JCO.20.01757","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-99. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15704","article-title":"Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial","volume":"312","author":"Huang H","year":"2014","unstructured":"Huang H, Li X, Zhu J, et al.. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. JAMA. 2014, 312:2521-30. 10.1001\/jama.2014.15704","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475826-diffuse-large-b-cell-lymphoma-associated-with-exposure-to-agent-orange","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:10:58Z","timestamp":1780697458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475826-diffuse-large-b-cell-lymphoma-associated-with-exposure-to-agent-orange"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.110317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}